nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0663	0.126	CbGbCtD
Triamcinolone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0623	0.119	CbGbCtD
Triamcinolone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0623	0.119	CbGbCtD
Triamcinolone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0564	0.107	CbGbCtD
Triamcinolone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0564	0.107	CbGbCtD
Triamcinolone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0487	0.0925	CbGbCtD
Triamcinolone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0472	0.0898	CbGbCtD
Triamcinolone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0427	0.0812	CbGbCtD
Triamcinolone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0427	0.0812	CbGbCtD
Triamcinolone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.041	0.0779	CbGbCtD
Triamcinolone—SERPINA6—blood plasma—acquired immunodeficiency syndrome	0.0069	0.0908	CbGeAlD
Triamcinolone—NR3C1—nerve—acquired immunodeficiency syndrome	0.004	0.0526	CbGeAlD
Triamcinolone—BCHE—blood plasma—acquired immunodeficiency syndrome	0.0034	0.0447	CbGeAlD
Triamcinolone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00302	0.0398	CbGeAlD
Triamcinolone—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00295	0.0388	CbGeAlD
Triamcinolone—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00262	0.0344	CbGeAlD
Triamcinolone—SERPINA6—blood—acquired immunodeficiency syndrome	0.00253	0.0333	CbGeAlD
Triamcinolone—SERPINA6—bone marrow—acquired immunodeficiency syndrome	0.00245	0.0322	CbGeAlD
Triamcinolone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00229	0.0301	CbGeAlD
Triamcinolone—SERPINA6—lung—acquired immunodeficiency syndrome	0.00222	0.0292	CbGeAlD
Triamcinolone—SERPINA6—nervous system—acquired immunodeficiency syndrome	0.00205	0.027	CbGeAlD
Triamcinolone—SERPINA6—central nervous system—acquired immunodeficiency syndrome	0.00198	0.026	CbGeAlD
Triamcinolone—BCHE—skin of body—acquired immunodeficiency syndrome	0.00163	0.0215	CbGeAlD
Triamcinolone—SERPINA6—brain—acquired immunodeficiency syndrome	0.00157	0.0206	CbGeAlD
Triamcinolone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.00145	0.0191	CbGeAlD
Triamcinolone—BCHE—digestive system—acquired immunodeficiency syndrome	0.00131	0.0172	CbGeAlD
Triamcinolone—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00126	0.0165	CbGeAlD
Triamcinolone—BCHE—blood—acquired immunodeficiency syndrome	0.00124	0.0164	CbGeAlD
Triamcinolone—BCHE—bone marrow—acquired immunodeficiency syndrome	0.0012	0.0158	CbGeAlD
Triamcinolone—BCHE—spinal cord—acquired immunodeficiency syndrome	0.0012	0.0158	CbGeAlD
Triamcinolone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.00118	0.0155	CbGeAlD
Triamcinolone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00116	0.0153	CbGeAlD
Triamcinolone—BCHE—vagina—acquired immunodeficiency syndrome	0.00115	0.0152	CbGeAlD
Triamcinolone—NR3C1—blood—acquired immunodeficiency syndrome	0.00111	0.0146	CbGeAlD
Triamcinolone—BCHE—lung—acquired immunodeficiency syndrome	0.00109	0.0143	CbGeAlD
Triamcinolone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.00107	0.0141	CbGeAlD
Triamcinolone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.00107	0.014	CbGeAlD
Triamcinolone—NR3C1—vagina—acquired immunodeficiency syndrome	0.00103	0.0135	CbGeAlD
Triamcinolone—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00102	0.0134	CbGeAlD
Triamcinolone—BCHE—nervous system—acquired immunodeficiency syndrome	0.00101	0.0133	CbGeAlD
Triamcinolone—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00101	0.0132	CbGeAlD
Triamcinolone—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000972	0.0128	CbGeAlD
Triamcinolone—NR3C1—lung—acquired immunodeficiency syndrome	0.000971	0.0128	CbGeAlD
Triamcinolone—PTGS2—blood—acquired immunodeficiency syndrome	0.000958	0.0126	CbGeAlD
Triamcinolone—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000927	0.0122	CbGeAlD
Triamcinolone—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000923	0.0121	CbGeAlD
Triamcinolone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.000899	0.0118	CbGeAlD
Triamcinolone—PTGS2—vagina—acquired immunodeficiency syndrome	0.000888	0.0117	CbGeAlD
Triamcinolone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000879	0.0116	CbGeAlD
Triamcinolone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.000865	0.0114	CbGeAlD
Triamcinolone—PTGS2—lung—acquired immunodeficiency syndrome	0.00084	0.0111	CbGeAlD
Triamcinolone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000837	0.011	CbGeAlD
Triamcinolone—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000778	0.0102	CbGeAlD
Triamcinolone—BCHE—brain—acquired immunodeficiency syndrome	0.000772	0.0102	CbGeAlD
Triamcinolone—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000749	0.00986	CbGeAlD
Triamcinolone—BCHE—lymph node—acquired immunodeficiency syndrome	0.000746	0.00981	CbGeAlD
Triamcinolone—NR3C1—brain—acquired immunodeficiency syndrome	0.000687	0.00904	CbGeAlD
Triamcinolone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00068	0.00895	CbGeAlD
Triamcinolone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000664	0.00874	CbGeAlD
Triamcinolone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000655	0.00861	CbGeAlD
Triamcinolone—PTGS2—brain—acquired immunodeficiency syndrome	0.000595	0.00782	CbGeAlD
Triamcinolone—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000575	0.00756	CbGeAlD
Triamcinolone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000384	0.000965	CcSEcCtD
Triamcinolone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000384	0.000964	CcSEcCtD
Triamcinolone—Shock—Indinavir—acquired immunodeficiency syndrome	0.000383	0.000963	CcSEcCtD
Triamcinolone—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000383	0.000962	CcSEcCtD
Triamcinolone—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000382	0.00096	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000382	0.000959	CcSEcCtD
Triamcinolone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000381	0.000959	CcSEcCtD
Triamcinolone—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000381	0.000957	CcSEcCtD
Triamcinolone—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000379	0.000953	CcSEcCtD
Triamcinolone—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.000953	CcSEcCtD
Triamcinolone—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.000952	CcSEcCtD
Triamcinolone—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000377	0.000948	CcSEcCtD
Triamcinolone—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000377	0.000946	CcSEcCtD
Triamcinolone—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.000946	CcSEcCtD
Triamcinolone—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000376	0.000945	CcSEcCtD
Triamcinolone—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.000945	CcSEcCtD
Triamcinolone—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.000944	CcSEcCtD
Triamcinolone—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000375	0.000943	CcSEcCtD
Triamcinolone—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000373	0.000939	CcSEcCtD
Triamcinolone—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.000936	CcSEcCtD
Triamcinolone—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.000934	CcSEcCtD
Triamcinolone—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.00093	CcSEcCtD
Triamcinolone—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.000927	CcSEcCtD
Triamcinolone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.000924	CcSEcCtD
Triamcinolone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.000923	CcSEcCtD
Triamcinolone—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.000921	CcSEcCtD
Triamcinolone—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.000912	CcSEcCtD
Triamcinolone—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00091	CcSEcCtD
Triamcinolone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000362	0.000909	CcSEcCtD
Triamcinolone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.000908	CcSEcCtD
Triamcinolone—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00036	0.000904	CcSEcCtD
Triamcinolone—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.000903	CcSEcCtD
Triamcinolone—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.000903	CcSEcCtD
Triamcinolone—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.000902	CcSEcCtD
Triamcinolone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.000901	CcSEcCtD
Triamcinolone—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000358	0.0009	CcSEcCtD
Triamcinolone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000358	0.0009	CcSEcCtD
Triamcinolone—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.000899	CcSEcCtD
Triamcinolone—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.000896	CcSEcCtD
Triamcinolone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000356	0.000895	CcSEcCtD
Triamcinolone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.000894	CcSEcCtD
Triamcinolone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000355	0.000892	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000355	0.000892	CcSEcCtD
Triamcinolone—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000354	0.000891	CcSEcCtD
Triamcinolone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000353	0.000887	CcSEcCtD
Triamcinolone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000353	0.000887	CcSEcCtD
Triamcinolone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000352	0.000885	CcSEcCtD
Triamcinolone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000352	0.000885	CcSEcCtD
Triamcinolone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.000881	CcSEcCtD
Triamcinolone—Rash—Didanosine—acquired immunodeficiency syndrome	0.00035	0.00088	CcSEcCtD
Triamcinolone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00035	0.000879	CcSEcCtD
Triamcinolone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00035	0.000879	CcSEcCtD
Triamcinolone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00035	0.000879	CcSEcCtD
Triamcinolone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00035	0.000879	CcSEcCtD
Triamcinolone—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.000875	CcSEcCtD
Triamcinolone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000348	0.000874	CcSEcCtD
Triamcinolone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000347	0.000873	CcSEcCtD
Triamcinolone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000347	0.000872	CcSEcCtD
Triamcinolone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.000871	CcSEcCtD
Triamcinolone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.00087	CcSEcCtD
Triamcinolone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000346	0.000869	CcSEcCtD
Triamcinolone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.000869	CcSEcCtD
Triamcinolone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000345	0.000867	CcSEcCtD
Triamcinolone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.000867	CcSEcCtD
Triamcinolone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.000866	CcSEcCtD
Triamcinolone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.000866	CcSEcCtD
Triamcinolone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.000864	CcSEcCtD
Triamcinolone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000343	0.000862	CcSEcCtD
Triamcinolone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00086	CcSEcCtD
Triamcinolone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000341	0.000857	CcSEcCtD
Triamcinolone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000341	0.000856	CcSEcCtD
Triamcinolone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.000856	CcSEcCtD
Triamcinolone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.000854	CcSEcCtD
Triamcinolone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.000854	CcSEcCtD
Triamcinolone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.000848	CcSEcCtD
Triamcinolone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000336	0.000844	CcSEcCtD
Triamcinolone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000336	0.000844	CcSEcCtD
Triamcinolone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.000844	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.000843	CcSEcCtD
Triamcinolone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.000842	CcSEcCtD
Triamcinolone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.000841	CcSEcCtD
Triamcinolone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000333	0.000837	CcSEcCtD
Triamcinolone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.000837	CcSEcCtD
Triamcinolone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.000836	CcSEcCtD
Triamcinolone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000333	0.000836	CcSEcCtD
Triamcinolone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.000835	CcSEcCtD
Triamcinolone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000833	CcSEcCtD
Triamcinolone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.000832	CcSEcCtD
Triamcinolone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.000831	CcSEcCtD
Triamcinolone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.00083	CcSEcCtD
Triamcinolone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00033	0.000829	CcSEcCtD
Triamcinolone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.000827	CcSEcCtD
Triamcinolone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.000826	CcSEcCtD
Triamcinolone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.000825	CcSEcCtD
Triamcinolone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.000822	CcSEcCtD
Triamcinolone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.000818	CcSEcCtD
Triamcinolone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.000814	CcSEcCtD
Triamcinolone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.000812	CcSEcCtD
Triamcinolone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.000809	CcSEcCtD
Triamcinolone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000321	0.000807	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000321	0.000806	CcSEcCtD
Triamcinolone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.000805	CcSEcCtD
Triamcinolone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.000804	CcSEcCtD
Triamcinolone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.000804	CcSEcCtD
Triamcinolone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00032	0.000803	CcSEcCtD
Triamcinolone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000319	0.000801	CcSEcCtD
Triamcinolone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.0008	CcSEcCtD
Triamcinolone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.000799	CcSEcCtD
Triamcinolone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.000798	CcSEcCtD
Triamcinolone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000317	0.000798	CcSEcCtD
Triamcinolone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000797	CcSEcCtD
Triamcinolone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.000795	CcSEcCtD
Triamcinolone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.000791	CcSEcCtD
Triamcinolone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.000791	CcSEcCtD
Triamcinolone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.000791	CcSEcCtD
Triamcinolone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000314	0.00079	CcSEcCtD
Triamcinolone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.000789	CcSEcCtD
Triamcinolone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000314	0.000789	CcSEcCtD
Triamcinolone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.000788	CcSEcCtD
Triamcinolone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000313	0.000786	CcSEcCtD
Triamcinolone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.000784	CcSEcCtD
Triamcinolone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.000783	CcSEcCtD
Triamcinolone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.000779	CcSEcCtD
Triamcinolone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000309	0.000778	CcSEcCtD
Triamcinolone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000775	CcSEcCtD
Triamcinolone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.000775	CcSEcCtD
Triamcinolone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000308	0.000774	CcSEcCtD
Triamcinolone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000307	0.000772	CcSEcCtD
Triamcinolone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000306	0.00077	CcSEcCtD
Triamcinolone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.000767	CcSEcCtD
Triamcinolone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.000766	CcSEcCtD
Triamcinolone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.000765	CcSEcCtD
Triamcinolone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000304	0.000764	CcSEcCtD
Triamcinolone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.000763	CcSEcCtD
Triamcinolone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000304	0.000763	CcSEcCtD
Triamcinolone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.000762	CcSEcCtD
Triamcinolone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.000762	CcSEcCtD
Triamcinolone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000303	0.000761	CcSEcCtD
Triamcinolone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000302	0.000759	CcSEcCtD
Triamcinolone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000302	0.000759	CcSEcCtD
Triamcinolone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000757	CcSEcCtD
Triamcinolone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.000755	CcSEcCtD
Triamcinolone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000299	0.000752	CcSEcCtD
Triamcinolone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000299	0.000752	CcSEcCtD
Triamcinolone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.000751	CcSEcCtD
Triamcinolone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.000751	CcSEcCtD
Triamcinolone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000297	0.000747	CcSEcCtD
Triamcinolone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.000747	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.000746	CcSEcCtD
Triamcinolone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000296	0.000745	CcSEcCtD
Triamcinolone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.000745	CcSEcCtD
Triamcinolone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.00074	CcSEcCtD
Triamcinolone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000739	CcSEcCtD
Triamcinolone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.000735	CcSEcCtD
Triamcinolone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.000735	CcSEcCtD
Triamcinolone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.000731	CcSEcCtD
Triamcinolone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00073	CcSEcCtD
Triamcinolone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.000729	CcSEcCtD
Triamcinolone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.000726	CcSEcCtD
Triamcinolone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000287	0.000722	CcSEcCtD
Triamcinolone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000287	0.000721	CcSEcCtD
Triamcinolone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00072	CcSEcCtD
Triamcinolone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000286	0.000719	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.000718	CcSEcCtD
Triamcinolone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.000712	CcSEcCtD
Triamcinolone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000282	0.000709	CcSEcCtD
Triamcinolone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.000707	CcSEcCtD
Triamcinolone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000706	CcSEcCtD
Triamcinolone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.000703	CcSEcCtD
Triamcinolone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00028	0.000702	CcSEcCtD
Triamcinolone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.000702	CcSEcCtD
Triamcinolone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.0007	CcSEcCtD
Triamcinolone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.0007	CcSEcCtD
Triamcinolone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000277	0.000696	CcSEcCtD
Triamcinolone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.000693	CcSEcCtD
Triamcinolone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000276	0.000693	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.000685	CcSEcCtD
Triamcinolone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.000682	CcSEcCtD
Triamcinolone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00068	CcSEcCtD
Triamcinolone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000679	CcSEcCtD
Triamcinolone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000675	CcSEcCtD
Triamcinolone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.000674	CcSEcCtD
Triamcinolone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.000674	CcSEcCtD
Triamcinolone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00067	CcSEcCtD
Triamcinolone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.000669	CcSEcCtD
Triamcinolone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.000664	CcSEcCtD
Triamcinolone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000664	CcSEcCtD
Triamcinolone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.000663	CcSEcCtD
Triamcinolone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.000662	CcSEcCtD
Triamcinolone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.000659	CcSEcCtD
Triamcinolone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000654	CcSEcCtD
Triamcinolone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.000652	CcSEcCtD
Triamcinolone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00065	CcSEcCtD
Triamcinolone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.000649	CcSEcCtD
Triamcinolone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000648	CcSEcCtD
Triamcinolone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000647	CcSEcCtD
Triamcinolone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000647	CcSEcCtD
Triamcinolone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.000643	CcSEcCtD
Triamcinolone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.000635	CcSEcCtD
Triamcinolone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000626	CcSEcCtD
Triamcinolone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000626	CcSEcCtD
Triamcinolone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.000625	CcSEcCtD
Triamcinolone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.000623	CcSEcCtD
Triamcinolone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000248	0.000622	CcSEcCtD
Triamcinolone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.000619	CcSEcCtD
Triamcinolone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000246	0.000617	CcSEcCtD
Triamcinolone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000245	0.000617	CcSEcCtD
Triamcinolone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000244	0.000613	CcSEcCtD
Triamcinolone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000612	CcSEcCtD
Triamcinolone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.000603	CcSEcCtD
Triamcinolone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000597	CcSEcCtD
Triamcinolone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000594	CcSEcCtD
Triamcinolone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000588	CcSEcCtD
Triamcinolone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000587	CcSEcCtD
Triamcinolone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.000585	CcSEcCtD
Triamcinolone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.000583	CcSEcCtD
Triamcinolone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.000583	CcSEcCtD
Triamcinolone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000582	CcSEcCtD
Triamcinolone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00058	CcSEcCtD
Triamcinolone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.000579	CcSEcCtD
Triamcinolone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000579	CcSEcCtD
Triamcinolone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000565	CcSEcCtD
Triamcinolone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000563	CcSEcCtD
Triamcinolone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000558	CcSEcCtD
Triamcinolone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000558	CcSEcCtD
Triamcinolone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000557	CcSEcCtD
Triamcinolone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000554	CcSEcCtD
Triamcinolone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000554	CcSEcCtD
Triamcinolone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000549	CcSEcCtD
Triamcinolone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000541	CcSEcCtD
Triamcinolone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000539	CcSEcCtD
Triamcinolone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000532	CcSEcCtD
Triamcinolone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000526	CcSEcCtD
Triamcinolone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000521	CcSEcCtD
Triamcinolone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00052	CcSEcCtD
Triamcinolone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000516	CcSEcCtD
Triamcinolone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000516	CcSEcCtD
Triamcinolone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000513	CcSEcCtD
Triamcinolone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000501	CcSEcCtD
Triamcinolone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000497	CcSEcCtD
Triamcinolone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000497	CcSEcCtD
Triamcinolone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000496	CcSEcCtD
Triamcinolone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000493	CcSEcCtD
Triamcinolone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000486	CcSEcCtD
Triamcinolone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000478	CcSEcCtD
Triamcinolone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000474	CcSEcCtD
Triamcinolone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000473	CcSEcCtD
Triamcinolone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000471	CcSEcCtD
Triamcinolone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000468	CcSEcCtD
Triamcinolone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000446	CcSEcCtD
